‘Epic waste of $500 million’: Scientists slam HHS funding for ‘next-gen’ COVID oral and nasal jab trials
The Biomedical Advanced Research and Development Authority is funding trials for ‘next-gen’ nasal and oral COVID shots. Scientists cautioned about potential vaccine shedding and long-term efficacy while criticizing the use of existing mRNA vaccines as comparators in the studies.
•